Faculty
Robert H Mach, Ph.D.
Britton Chance Professor of Radiology
Department: Radiology
Graduate Group Affiliations
Contact information
Department of Radiology
Vagelos Laboratory, Rm 1012
231 S. 34th Street
Philadelphia, PA 19104
Vagelos Laboratory, Rm 1012
231 S. 34th Street
Philadelphia, PA 19104
Office: 215-746-8233
Email:
rmach@pennmedicine.upenn.edu
rmach@pennmedicine.upenn.edu
Publications
Education:
B.A. (Chemistry)
State University of New York, College at Potsdam, 1978.
Ph.D. (Medical Chemistry)
State University of New York at Buffalo, Buffalo, NY, 1985.
Permanent linkB.A. (Chemistry)
State University of New York, College at Potsdam, 1978.
Ph.D. (Medical Chemistry)
State University of New York at Buffalo, Buffalo, NY, 1985.
Description of Research Expertise
Research Interests. Research in my lab is focused on development of radiotracers for studying the molecular basis of disease using the imaging technique, positron emission tomography or PET.Keywords. Dopamine D3 receptors, alpha synuclein, PARP-1, neurodegeneration, addiction.
Research Details. My current research projects include the development of radiotracers for imaging: 1) dopamine D3 receptors in addiction; 2) alpha synuclein in Parkinson’s disease and other synucleinopathies; and 3) PARP-1 in cancer and CNS disorders. My laboratory is also studying cancer cell biology, and identified the role of a ternary complex between the sigma-2 receptor/TMEM97, LDL receptor, and progesterone receptor membrane component 1 (PGRMC1) in providing the high levels of cholesterol needed to support cell proliferation.
Rotation Projects. 1) In silico and computational chemistry methods for identifying small molecule - protein interactions. 2) Mechanism of receptor mediated internalization mediated by the TMEM97-sigma-2 receptor/PGRMC1 protein complex. 3) Molecular imaging of CNS receptors with PET.
Lab Personnel. The Mach lab currently has 1 graduate student, 3 postdoctoral research associates in cell biology, 3 postdoctoral research associates in chemistry and 5 support staff.
Selected Publications
Stehouwer JS, Huang G, Saturnino Guarino D, Debnath ML, Polu A, Geib SJ, Lopresti B, Ikonomovic MD, Mason N, Mach RH, Mathis CA: Structure-Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1 H-indoles as Tauopathy Positron Emission Tomography Radiotracers. Journal of Medicinal Chemistry. ACS, Vol 68/Issue 6: 6462-6492, Mar 2025 Notes: J Med Chem. 2025 Mar 27;68(6):6462-6492. doi: 10.1021/acs.jmedchem.4c02988. Epub 2025 Mar 11. PMID: 40068019 PMCID: PMC11956013 DOI: 10.1021/acs.jmedchem.4c02988.Dubroff JG, Hsieh CJ, Wiers CE, Lee H, Li EJ, Schubert EK, Mach RH, Kranzler HR: [11C]Carfentanil PET Whole-Body Imaging of Mu-Opioid Receptors: A First In-Human Study. J. Nucl. Med. J. Nucl. Med, 66(1112-1118): 1112-1118, July 2025.
Hsieh C-J, Saturnino Guarino D, Young AJ, Siderowf AD, Nasrallah I, Schmitz A, Garcia C, Kim HY, Schubert EK, Lee H, Perlmutter JS, Mach RH: Pilot Study of [11C]HY-2-15: A Mixed Alpha-Synuclein and Tau PET Radiotracer. Cells. MDPI, 14(1157), July 2025.
Zhao H, Huang T, Dhavale DD, O’Shea JY, Lengyel-Zhand Z, Saturnino Guarino D, Gu J, Yue X, Nai Y-H, Jiang H, Lougee MG, Pagar VV, Kim HJ, Garcia BA, Petersson EJ, Mathis CA, Kotzbauer P, Perlmutter JS, Mach RH, Tu Z: Discovery of N-(6-Methoxypyridin-3-yl)quinoline-2-amine Derivatives for Imaging Aggregated α-Synuclein in Parkinson's Disease with Positron Emission Tomography. Cells. MDPI, 14(1108), July 2025.
Burström V, Xu K, Garro-Martínez E, Mach RH, Sahlholm K, Nibal Betari N: A Nanoluciferase Complementation-based Assay for Monitoring β-arrestin2 Recruitment to the Dopamine D3 Receptor. Biochemistry and Biophysics Reports. Elsevier B.V. 42(102019), April 2025.
Tian GL, Hsieh CJ, Guarino DS, Graham TJA, Lengyel-Zhand Z, Schmitz A, Chia WK, Young AJ, Crosby JG, Plakas K, Huang T, Jiang H, Yu Y, Hou C, Lee H, Petersson EJ, Giannakoulias S, O'Shea J, Kotzbauer P, Tu Z, Mathis CA, Mach RH: The Development of a PET Radiotracer for Imaging Alpha Synuclein Aggregates in Parkinson’s Disease. RSC Med Chem RSC Med Chem 10(1039), April 2025.
Li S, Schmitz A, Lu YT, Pal R, Sarkar S, Sellmyer MA, Mach RH, Lee H: Evaluation of a Simplified Radiolabeling Method for a PARP Inhibitor in an Animal Model of Breast Cancer. EJNMMI Research Springer Nature, 15(50), April 2025.
Stehouwer JS, Huang G, Saturnino Guarino D, Debnath ML, Polu A, Geib SJ, Lopresti B, Ikonomovic MD, Mason N, Mach RH, Mathis CA: Structure-Activity Relationships and Evaluation of 2-(Heteroaryl-cycloalkyl)-1 H-indoles as Tauopathy Positron Emission Tomography Radiotracers. J Med. Chem. J Med. Chem, 68(6462-6492), March 2025.
Plakas K, Hsieh CJ, Guarino DS, Hou C, Chia WK, Young A, Schmitz A, Ho YP, Weng CC, Lee H, Li S, Graham TJA, Mach RH: Toward a Small Molecule Antagonist Radioligand for Positron Emission Tomography Imaging of the Mu Opioid Receptor. ACS Chem. Neurosci. ACS, 16(1592-1603), March 2025.
Blizard GS, Dwivedi G, Pan YG, Hou C, Etersque JM, Said H, Chevrier A, Lavertu M, Ni H, Davis B, Tam Y, Cao Q, Mach RH, Weissman D, Alameh MG, Sellmyer MA.: Monitoring mRNA vaccine antigen expression in vivo using PET/CT. Nature Communications 16(1):2234, Mar 2025 Notes: Nat Commun. 2025 Mar 6;16(1):2234. doi: 10.1038/s41467-025-57446-w. PMID: 40044669 PMCID: PMC11882883
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Site Design: PMACS Web Team.